UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

A Phase 2 Trial of Ponatinib in Philadelphia Chromosome–Positive Leukemias

The New England journal of medicine, 2013-11, Vol.369 (19), p.1783-1796

2013

Volltextzugriff (PDF)

Six-year follow-up of patients receiving imatinib for the first-line treatment of chronic myeloid leukemia

Leukemia, 2009-06, Vol.23 (6), p.1054-1061

2009

Volltextzugriff (PDF)

Regional differences in the pituitary distribution of luteinizing hormone in the gonadectomized and proestrous female rat

General and comparative endocrinology, 2008-05, Vol.156 (3), p.577-583

2008

Volltextzugriff (PDF)

The Third International Congress on Myeloproliferative and Myelodysplastic Syndromes

Leukemia research, 2007-01, Vol.31 (1), p.11-17

2007

Volltextzugriff (PDF)

Prognostic factors for outcomes in allogeneic transplantation for CML in the imatinib era: a CIBMTR analysis

Bone marrow transplantation (Basingstoke), 2012-06, Vol.47 (6), p.810-816

2012

Volltextzugriff (PDF)

Chronic anemia due to parvovirus B19 infection in a bone marrow transplant patient after platelet transfusion

Transfusion (Philadelphia, Pa.), 1997-09, Vol.37 (9), p.947-952

1997

Volltextzugriff (PDF)

Diverging effects of HLA-DPB1 matching status on outcome following unrelated donor transplantation depending on disease stage and the degree of matching for other HLA alleles

Leukemia, 2010-01, Vol.24 (1), p.58-65

2010

Volltextzugriff (PDF)

KIR2DS1 genotype predicts for complete cytogenetic response and survival in newly diagnosed chronic myeloid leukemia patients treated with imatinib

Leukemia, 2012-02, Vol.26 (2), p.296-302

2012

Volltextzugriff (PDF)

Allogeneic stem cell transplantation for chronic myeloid leukemia-status in 2007

Bone marrow transplantation (Basingstoke), 2008-08, Vol.42 (S1), p.S11-S13

Goldman, Jm

2008

Volltextzugriff (PDF)

Historique de la leucémie myéloïde chronique : un paradigme de traitement du cancerCet article est entièrement dédié à la mémoire du Professeur John M. Goldman, décédé le 24 décembre 2013. This manuscript is entirely devoted to the memory of sir Professor John M. Goldman, deceased the 24th of December 2013

Bulletin du cancer, 2014-01, Vol.101 (1), p.56-67

2014

Volltextzugriff (PDF)

hOCT1 transcript levels and single nucleotide polymorphisms as predictive factors for response to imatinib in chronic myeloid leukemia

Leukemia, 2010-06, Vol.24 (6), p.1243-1245

2010

Volltextzugriff (PDF)

Hematopoietic stem cells and progenitors of chronic myeloid leukemia express leukemia-associated antigens: implications for the graft-versus-leukemia effect and peptide vaccine-based immunotherapy

Leukemia, 2008-09, Vol.22 (9), p.1721-1727

2008

Volltextzugriff (PDF)

Chronic myeloproliferative diseases with and without the Ph chromosome: some unresolved issues

Leukemia, 2009-10, Vol.23 (10), p.1708-1715

2009

Volltextzugriff (PDF)

Historique de la leucémie myéloïde chronique: un paradigme de traitement du cancer

Bulletin du cancer, 2014, Vol.101 (1), p.56-67

2014

Volltextzugriff (PDF)

Multiple sub-microscopic genomic lesions are a universal feature of chronic myeloid leukaemia at diagnosis

Leukemia, 2008-09, Vol.22 (9), p.1806-1807

2008

Volltextzugriff (PDF)

Severe allergic reaction with anaphylaxis to G-CSF (lenograstim) in a healthy donor

Bone marrow transplantation (Basingstoke), 2009-07, Vol.44 (2), p.129-130

2009

Volltextzugriff (PDF)

Drug responses of imatinib mesylate-resistant cells: synergism of imatinib with other chemotherapeutic drugs

Leukemia, 2002-12, Vol.16 (12), p.2349-2357

2002

Volltextzugriff (PDF)

Factors for graft‐versus‐host disease after donor lymphocyte infusions with an escalating dose regimen: lack of association with cell dose

British journal of haematology, 2007-03, Vol.136 (6), p.833-836

2007

Volltextzugriff (PDF)

Future perspectives

Bone marrow transplantation (Basingstoke), 2010-05, Vol.45 (5), p.843-845

2010

Volltextzugriff (PDF)

Impact of Hemochromatosis Gene (HFE) Polymorphisms and Iron Overload on Outcome of Allogeneic Stem Cell Transplantation for Chronic Myeloid Leukemia

Biology of blood and marrow transplantation, 2012, Vol.18 (2), p.S210-S210

2012

Volltextzugriff (PDF)

BCR-ABL1-positive CML and BCR-ABL1-negative chronic myeloproliferative disorders : some common and contrasting features

Leukemia, 2008-11, Vol.22 (11), p.1975-1989

2008

Volltextzugriff (PDF)

hOCT1 transcript levels and single nucleotide polymorphisms as predictive factors for response to imatinib in chronic myeloid leukemia

Leukemia, 2010-06, Vol.24 (6), p.1243

2010

Volltextzugriff (PDF)

Effects of low subchronic doses of methoxychlor on the rat hypothalamic-pituitary reproductive axis

Toxicology and applied pharmacology, 1986-12, Vol.86 (3), p.474-483

1986

Volltextzugriff (PDF)

Risk Score Predicts Outcome of Second Allogeneic Hematopoietic Stem Cell Transplantation

Biology of blood and marrow transplantation, 2011, Vol.17 (2), p.S155-S155

2011

Volltextzugriff (PDF)

Six-year follow-up of patients receiving imatinib for the first-line treatment of chronic myeloid leukemia

Leukemia, 2010-05, Vol.24 (5), p.1102-1102

2010

Volltextzugriff (PDF)

1 – 25 von 298

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(255)
Mit Volltextzugriff
(258)

Publikationsform

Sprache

Englisch
(296)
Französisch
(2)

Erscheinungsjahr

n.n

Thema

Science & Technology
(172)
Life Sciences & Biomedicine
(118)
Humans
(110)
Biological And Medical Sciences
(64)
Medical Sciences
(56)
Female
(52)
Male
(50)
Adult
(47)
Physical Sciences
(42)
Hematology
(39)
Middle Aged
(34)
Physics
(29)
Adolescent
(26)
Hematologic And Hematopoietic Diseases
(26)
Leukemias. Malignant Lymphomas. Malignant Reticulosis. Myelofibrosis
(26)
Oncology
(26)
Animals
(24)
Aged
(23)
Technology
(19)
Child
(18)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(2)
... seit 90 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

A Phase 2 Trial of Ponatinib in Philadelphia Chromosome–Positive Leukemias

Six-year follow-up of patients receiving imatinib for the first-line treatment of chronic myeloid leukemia

Regional differences in the pituitary distribution of luteinizing hormone in the gonadectomized and proestrous female rat

The Third International Congress on Myeloproliferative and Myelodysplastic Syndromes

Prognostic factors for outcomes in allogeneic transplantation for CML in the imatinib era: a CIBMTR analysis

Chronic anemia due to parvovirus B19 infection in a bone marrow transplant patient after platelet transfusion

Diverging effects of HLA-DPB1 matching status on outcome following unrelated donor transplantation depending on disease stage and the degree of matching for other HLA alleles

KIR2DS1 genotype predicts for complete cytogenetic response and survival in newly diagnosed chronic myeloid leukemia patients treated with imatinib

Allogeneic stem cell transplantation for chronic myeloid leukemia-status in 2007

hOCT1 transcript levels and single nucleotide polymorphisms as predictive factors for response to imatinib in chronic myeloid leukemia

Hematopoietic stem cells and progenitors of chronic myeloid leukemia express leukemia-associated antigens: implications for the graft-versus-leukemia effect and peptide vaccine-based immunotherapy

Chronic myeloproliferative diseases with and without the Ph chromosome: some unresolved issues

Historique de la leucémie myéloïde chronique: un paradigme de traitement du cancer

Multiple sub-microscopic genomic lesions are a universal feature of chronic myeloid leukaemia at diagnosis

Severe allergic reaction with anaphylaxis to G-CSF (lenograstim) in a healthy donor

Drug responses of imatinib mesylate-resistant cells: synergism of imatinib with other chemotherapeutic drugs

Factors for graft‐versus‐host disease after donor lymphocyte infusions with an escalating dose regimen: lack of association with cell dose

Future perspectives

Impact of Hemochromatosis Gene (HFE) Polymorphisms and Iron Overload on Outcome of Allogeneic Stem Cell Transplantation for Chronic Myeloid Leukemia

BCR-ABL1-positive CML and BCR-ABL1-negative chronic myeloproliferative disorders : some common and contrasting features

hOCT1 transcript levels and single nucleotide polymorphisms as predictive factors for response to imatinib in chronic myeloid leukemia

Effects of low subchronic doses of methoxychlor on the rat hypothalamic-pituitary reproductive axis

Risk Score Predicts Outcome of Second Allogeneic Hematopoietic Stem Cell Transplantation

Six-year follow-up of patients receiving imatinib for the first-line treatment of chronic myeloid leukemia

Suchergebnisse filtern